Cumulative effects of exercise training and consumption of propolis on managing diabetic dyslipidemia in adult women: a single-blind, randomized, controlled trial with pre-post-intervention assessments

J Physiol Sci. 2023 Aug 5;73(1):17. doi: 10.1186/s12576-023-00872-6.

Abstract

Dyslipidemia is an imbalance of various lipids, and propolis, as a natural resinous viscos mixture made by Apis mellifera L. could improve in this condition. In this single-blind, randomized trial, 60 women with type 2 diabetes and dyslipidemia were divided into four groups: (1) the patients who did not apply the combined training and 500 mg propolis capsules supplement (Control group); (2) subjects performed combined training, including aerobic and resistance training (EXR); (3) subjects received the 500 mg propolis supplement capsules (SUPP); (4) Subjects performed combined training along with receiving the 500 mg propolis supplement capsules (EXR + SUPP). We evaluated the concentration of CTRP12, SFRP5, interleukin-6 (IL6), superoxide dismutase (SOD), malondialdehyde (MDA), adiponectin, and total antioxidant capacity (TAC) before and after the intervention. MDA, TAC, IL6, CTRP12, SFRP5 IL6, adiponectin, and lipid profile levels ameliorated in the EXR + SUPP group. We found that 8 weeks of treatment by combined exercise training and propolis supplement decreased inflammation activity and increased antioxidant defense in women with diabetic dyslipidemia.Trial registration This study was registered in the Iranian Registry of Clinical Trials; IRCT code: IRCT20211229053561N1.

Keywords: C1QTNF12; Computational molecular biology; Exercise training; Propolis; SFRP5.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adiponectin / pharmacology
  • Adiponectin / therapeutic use
  • Adult
  • Animals
  • Antioxidants / pharmacology
  • Capsules / pharmacology
  • Capsules / therapeutic use
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Female
  • Humans
  • Interleukin-6
  • Iran
  • Oxidative Stress
  • Propolis* / pharmacology
  • Propolis* / therapeutic use
  • Single-Blind Method

Substances

  • Propolis
  • Antioxidants
  • Adiponectin
  • Capsules
  • Interleukin-6

Associated data

  • IRCT/IRCT20211229053561N1